Tag Archives: COVID-19

Representative Image: Reuters Pfizer Inc said Tuesday that participants showed mild to moderate side effects when given the company’s experimental coronavirus vaccine or a placebo in an ongoing late-stage study. Reuters Last update: September 16, 2020 8:35 AM M. IST FOLLOW US: Pfizer Inc said Tuesday that participants showed mild …

India registered 90,123 new cases of the coronavirus disease on Wednesday, according to the update from the Union Ministry of Health. The total number of cases now stands at 5.02.0359. The number of active cases has approached one million; it is currently at 9.95,933, according to the Ministry of Health. …

India reported 90,123 new cases of covid-19 on Wednesday. With this, India became the second country in the world to cross the five million mark after the United States. With the single-day peak of 90,123 new positive covid-19 cases, India has reported a total of 50,20,360 cases, the Union Health …

US President Donald Trump said Tuesday that a coronavirus vaccine could be available within a month, an acceleration even from his own optimistic predictions, but added that the pandemic could go away on its own. “We are very close to having a vaccine,” he said in a city hall question …

President Donald Trump again raised hope – and concern – about swift U.S. approval for a coronavirus vaccine, saying at a city hall event hosted by ABC News that the vaccine could be ready within four weeks. “The previous administration would have taken maybe years to have a vaccine, due …

At home, market participants will observe these global signals, but they are likely to focus primarily on individual stocks. They will also track the RBI Governor’s speech to the Ficci members today at 11 AM. Also, Covid-19 trends and news flow on the India-China front will be closely monitored. In …

“Cadila and Bharat Biotech have completed phase I trials. Serum Institute has completed phase II-B3 trials and will begin phase III trial (with 1,500 patients at 14 locations) after authorizations,” said Balram Bhargava, DG. , ICMR. Phase I clinical trials have revealed “excellent safety” of the two candidate vaccines developed …

On Tuesday, the government praised India’s Covid-19 recovery rate, standing at 78.28%, and said it was one of the highest in the world, citing data from the University’s coronavirus disease tracker. Johns Hopkins. Balram Bhargava, director general of the Indian Council for Medical Research (ICMR), attributed the “very effective” blockade …

Fifteen scientists from five countries signed the letter presenting their concerns to the international medical journal, Enrico Bucci, an associate professor biologist at Temple University in Philadelphia, told Reuters. Reuters did not see the content of the letter. Nonetheless, the move highlights growing concern among scientists about the safety and …

The Indian Council for Medical Research (ICMR) said on Tuesday that three candidate vaccines against the coronavirus disease (Covid-19) are in the clinical stage of trials in India and one of them will soon begin Phase 3 trials after obtaining authorizations. The Covid-19 vaccine candidates made by Cadila Healthcare and …